Dexcom shares sank more than 40% on Friday, their steepest decline ever, after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. The stock fell $43.85 to close at $64, wiping out more than $17 billion in market cap. Prior to Friday, the biggest...
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Friday reported second-quarter earnings and revenue that topped expectations and raised its full-year guidance as the drugmaker moves to slash...
American shares drop 7% on weak profit forecast after backfired sales plan, industry oversupply
An American Airlines Boeing 737 MAX 8 aircraft approaches San Diego International Airport for a landing from Phoenix on June 28, 2024 in San Diego, California. Kevin Carter | Getty Images American Airlines shares shed more than 7% in premarket trading Thursday after the carrier slashed its profit forecast...
AT&T beats estimates for subscriber additions on demand for higher-priced plans
AT&T exceeded market expectations for wireless subscriber additions in the second quarter on Wednesday, as the telecom operator's higher-tier unlimited plans attracted customers. The company added 419,000 monthly bill-paying wireless phone subscribers, compared with expectations of 284,800 additions, according to five analysts polled by FactSet. AT&T's unlimited plans that...